Department of Health
and Human Services (HHS)
and Human Services (HHS)
June 5, 2020
PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)."
National Institute on Deafness and Other Communication Disorders (NIDCD)
The purpose of this Notice to inform potential applicants that the National Institute on Deafness and Other Communication Disorders (NIDCD) will participate, effective immediately, in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)."
The following changes and updates are made toPA-20-135(shown in italics) to reflect NIDCD’s participation in this FOA.
Part 1. Overview Information
Components of Participating Organizations
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Office of Strategic Coordination (Common Fund)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.213, 93.393, 93.394, 93.395, 93.396, 93.399, 93.172, 93.855, 93.865, 93.847, 93.113, 93.142, 93.143, 93.859, 93.307, 93.286,93.273, 93.310, 93.173
All other aspects of PA-20-135 remain unchanged.
Janet L. Cyr, Ph.D.
NIDCD/Division of Scientific Programs
Telephone: 301-402-3458
Email: cyrj@nidcd.nih.gov